Applied DNA Sciences plans to raise up to $58 million in a private placement to launch its BNB financial strategy.

Applied DNA Sciences, Inc. (NASDAQ: APDN), a biotechnology company, announced that it has received commitments for up to $58 million in a private investment in publicly traded equity (PIPE) led by institutional investors to launch its BNB-based digital asset finance strategy.